Sinovac Biotech, Ltd (SVA) Misses Q3 EPS by 3c
Get Alerts SVA Hot Sheet
Join SI Premium – FREE
Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q3 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $12.35 million.
For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.
For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Meta earnings, IBM to acquire HashiCorp, U.S. GDP ahead - what's moving markets
- Analysts favorite fintech stock Adyen tumbles after revenue miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!